Multiple Myeloma in Relapse Recruiting Phase 1 / 2 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01794572Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma RelapseTreatment